Furthermore, liver-specific overexpression of NRF1 dramatically increased proteasome abundance and ameliorated MASH, as evidenced by the alleviation of steatosis, mitigation of liver damage, decreased infiltration of inflammatory cells and inhibition of hepatic fibrosis. This evidence concerns the gene NRF1 and steatosis.